25 Reasons to Avoid the Gardasil Vaccine that Never Should Have Been Approved by the FDA

25 Reasons to Avoid the Gardasil Vaccine that Never Should Have Been Approved by the FDA

In the only Gardasil trial in the target age group (11- and 12-year-old girls) with a control group design, fewer than 1200 children received the vaccine and fewer than 600 served as controls. This single trial involving fewer than 1800 children set the stage for the vaccine’s subsequent marketing to millions of healthy preteens all over the world.
The Gardasil clinical trials had numerous exclusion criteria. Not allowed to participate in the trials were people with: severe allergies; prior abnormal Pap test results; over four lifetime sex partners; a history of immunological disorders and other chronic illnesses; reactions to vaccine ingredients, including aluminum, yeast, and benzonase; or a history of drug or alcohol abuse—yet Merck now recommends Gardasil for all of these groups.
Inadequate monitoring
Some of the study participants—but not all—were given “report cards” to record short-term reactions such as redness and itching. The report cards monitored reactions for a mere 14 days, however, and Merck did not follow up with participants who experienced serious adverse events such as systemic autoimmune or menstrual problems.
Injured participants complained that Merck rebuffed their attempts to report adverse side effects. In numerous instances, Merck maintained that these “weren’t related to the vaccine.”
Half (49.6%) of the clinical trial subjects who received Gardasil reported serious medical conditions within seven months. To avoid classifying these injuries as adverse events, Merck dismissed them as “new medical conditions.”
Cervical cancer risk-benefit ratio not worth it
The median age of cervical cancer death is 58 years. Gardasil targets millions of healthy preadolescents and teens for whom the risk of dying from cervical cancer is practically zero. Interventions for healthy people must have a risk profile that is also practically zero.
Annual deaths from cervical cancer in the U.S. are 2.3/100,000. The death rate in the Gardasil clinical trials was 85/100,000—or 37 times that of cervical cancer.
With 76 million children vaccinated at an average cost of $420 for the three-shot Gardasil series, the cost of saving one American life from cervical cancer amounts to about $18.3 million dollars. By contrast, the value of a human life according to the Department of Health and Human Services’s (HHS’s) National Vaccine Injury Compensation Program is $250,000—the maximum amount that the government program will award for a vaccine-related death.
According to Gardasil’s package insert, women are 100 times more likely to suffer a severe event following vaccination with Gardasil than they are to get cervical cancer.
The chances of getting an autoimmune disease from Gardasil, even if the vaccine works, are 1,000 times greater than the chances of being saved from a cervical cancer death.
Women in Gardasil clinical trials with evidence of current HPV infection and previous exposure to HPV had a 44% increased risk of developing cervical lesions or cancer following vaccination.
Women who get the Gardasil vaccine as preteens or teens are more likely to skip cervical cancer screening as adults, mistakenly assuming that HPV vaccination is a replacement for screening and that the vaccine will eliminate all risk.
Fertility effects
Accumulating evidence points to Gardasil’s potentially severe adverse effects on fertility, including miscarriage and premature ovarian failure.
Merck never tested the vaccine for fertility effects. However, Gardasil and Gardasil 9 clinical trials showed high spontaneous miscarriage rates of 25% and 27.4%, respectively—significantly higher than the background rates of approximately 10%-15% in this reproductive age group.
Polysorbate 80 and sodium borate (Borax) are associated with infertility in animals. Both are Gardasil ingredients, and both were present in the one clinical trial protocol that professed to use a benign saline placebo.
Post-licensing
In 2015, Denmark opened five new “HPV clinics” to treat children injured by Gardasil. Over 1300 cases flooded the clinics shortly after their opening.
Since Gardasil came on the U.S. market in 2006, people have reported over 450 deaths and over 61,000 serious medical conditions from HPV vaccines to the Vaccine Adverse Event Reporting System (VAERS).
Merck lied to VAERS about the case of Christina Tarsell’s death, falsely claiming that her doctor blamed a virus instead of Gardasil. [Source: The HPV Vaccine on Trial  (p. 144).]

via Vaccine Impact 25 Reasons to Avoid the Gardasil Vaccine that Never Should Have Been Approved by the FDA